These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 9601846)
1. [Current views on use of megestrol acetate in oncology practice]. Vyzula R Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846 [TBL] [Abstract][Full Text] [Related]
2. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome]. Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M; Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739 [TBL] [Abstract][Full Text] [Related]
3. Treating malnutrition with megestrol acetate: literature review and review of our experience. Karcic E; Philpot C; Morley JE J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625 [TBL] [Abstract][Full Text] [Related]
4. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review). Strang P Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study. Bruera E; Ernst S; Hagen N; Spachynski K; Belzile M; Hanson J; Summers N; Brown B; Dulude H; Gallant G Cancer Prev Control; 1998 Apr; 2(2):74-8. PubMed ID: 9765767 [TBL] [Abstract][Full Text] [Related]
8. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate. Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858 [TBL] [Abstract][Full Text] [Related]
9. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758 [TBL] [Abstract][Full Text] [Related]
10. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)]. Desport JC; Blanc-Vincent MP; Gory-Delabaere G; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Scheiner S; Senesse P Bull Cancer; 2000 Apr; 87(4):315-28. PubMed ID: 10827350 [TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate for the palliation of anorexia in advanced, incurable cancer patients. Mateen F; Jatoi A Clin Nutr; 2006 Oct; 25(5):711-5. PubMed ID: 16867306 [TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Berenstein EG; Ortiz Z Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706 [TBL] [Abstract][Full Text] [Related]
13. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate. Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383 [TBL] [Abstract][Full Text] [Related]
15. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome. Madeddu C; Dessì M; Panzone F; Serpe R; Antoni G; Cau MC; Montaldo L; Mela Q; Mura M; Astara G; Tanca FM; Macciò A; Mantovani G Clin Nutr; 2012 Apr; 31(2):176-82. PubMed ID: 22047681 [TBL] [Abstract][Full Text] [Related]
16. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide. Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994 [TBL] [Abstract][Full Text] [Related]
17. Appetite stimulants: the unsolved truth. Baron M Health Care Food Nutr Focus; 2000 Jun; 16(10):5-7. PubMed ID: 11182996 [No Abstract] [Full Text] [Related]
18. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia. Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631 [TBL] [Abstract][Full Text] [Related]
19. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
20. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia. Couluris M; Mayer JL; Freyer DR; Sandler E; Xu P; Krischer JP J Pediatr Hematol Oncol; 2008 Nov; 30(11):791-7. PubMed ID: 18989154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]